Biosimilar arthritis drug under Real-World watch
NCT ID NCT06247722
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study follows 600 people with moderate to severe rheumatoid arthritis who are prescribed Tyenne, a biosimilar of tocilizumab. Researchers will track how long patients stay on the treatment over 12 months. The goal is to see how well the drug works in everyday medical practice, outside of controlled trial settings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Tyenne (tocilizumab biosimilar)
- What this could lead to
- If successful, this study could show that Tyenne works well in everyday use for rheumatoid arthritis, supporting its wider adoption.
- What could go wrong
- This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by patient selection or other factors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Facharztpraxis für Innere Medizin
Naumburg, 06618, Germany
-
Facharztpraxis für Innere Medizin Ludwigsfelde
Ludwigsfelde, 14974, Germany
-
Klinische Forschung
Planegg, 82152, Germany
-
Rheumahaus Potsdam
Potsdam, 14467, Germany
-
Rheumapraxis Dr. Liebhaber Halle
Halle, 06128, Germany
-
Rheumatologische Facharztpraxis
Magdeburg, 39104, Germany
-
Rheumatologische Facharztpraxis Templin
Templin, 17268, Germany
-
Rheumatologische Schwerpunktpraxis Berlin
Berlin, 12161, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test could end guesswork in rheumatoid arthritis treatment
- Experimental biologic CND319 takes first steps toward taming autoimmune diseases
- Could cord cell secretions ease arthritis pain?
- Which RA drug works best after the first one fails? a major trial aims to find out
- Could a once-every-few-weeks IV infusion tame rheumatoid arthritis?
- CT scans track hip implant movement to predict Long-Term stability